Cardiac dysfunction and ferritin as early markers of severity in pediatric sepsis;Disfunção cardíaca e a ferritina como marcadores precoces de gravidade na sepse pediátrica

Jornal de Pediatria

Volumn 93, Issue 3, 2017, Pages 301-307

  Tonial, Cristian T ^a   Garcia, Pedro Celiny R ^a,b   Schweitzer, Louise Cardoso ^a   Costa, Caroline A D ^a   Bruno, Francisco ^a   Fiori, Humberto H ^a   Einloft, Paulo R ^a   Garcia, Ricardo Branco ^c   Piva, Jefferson Pedro ^d,e  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Ministério de Ciência Tecnologia e Inovação Salvador   (Brazil)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Echocardiogram; Outcome; Pediatric intensive care unit; Sepsis; Septic shock

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; INOTROPIC AGENT; VASOACTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CHILD; CHILD HOSPITALIZATION; CLINICAL ARTICLE; COHORT ANALYSIS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART OUTPUT; HUMAN; HYPERFERRITINEMIA; INFANT; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; MORTALITY; NEWBORN; OUTCOME ASSESSMENT; PEDIATRIC INTENSIVE CARE UNIT; PROSPECTIVE STUDY; SEPSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; BLOOD; COMPLICATION; DOPPLER ECHOCARDIOGRAPHY; HEART; METABOLISM; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; BIOMARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FERRITINS; HEART; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; PROSPECTIVE STUDIES; SEPSIS;

EID: 85011350046     PISSN: 00217557     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jped.2016.08.006     Document Type: Article

References (23)

1. Simon, L., Gauvin, F., Amre, D.K., Lacroix, J., Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis 39 (2004), 206–217.
2. Rey, C., Los Arcos, M., Concha, A., Medina, A., Prieto, S., Martinez, P., et al. Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children. Intensive Care Med 33 (2007), 477–484.
3. Teng Chung, T., Hinds, C.J., Treatment with GH and IGF-1 in critical illness. Crit Care Clin 22 (2006), 29–40.
4. Vila Pérez, D., Jordan, I., Esteban, E., García-Soler, P., Murga, V., Bonil, V., et al. Prognostic factors in pediatric sepsis study, from the Spanish Society of Pediatric Intensive Care. Pediatr Infect Dis J 33 (2014), 152–157.
5. Van Leeuwen, H.J., Heezius, E.C., Dallinga, G.M., van Strijp, J.A., Verhoef, J., van Kessel, K.P., Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31 (2003), 1359–1366.
6. Garcia, P.C., Longhi, F., Branco, R.G., Piva, J.P., Lacks, D., Tasker, R.C., Ferritin levels in children with severe sepsis and septic shock. Acta Paediatr 96 (2007), 1829–1831.
7. Demirkol, D., Yildizdas, D., Bayrakci, B., Karapinar, B., Kendirli, T., Koroglu, T.F., et al. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?. Crit Care, 16, 2012, 52.
8. Raschke, R.A., Garcia-Orr, R., Hemophagocytic lymphohistiocytosis: a potentially underrecognized association with systemic inflammatory response syndrome, severe sepsis, and septic shock in adults. Chest 140 (2011), 933–938.
9. Raj, S., Killinger, J.S., Gonzalez, J.A., Lopez, L., Myocardial dysfunction in pediatric septic shock. J Pediatr 164 (2014), 72–77.
10. Smeding, L., Plötz, F.B., Groeneveld, A.B., Kneyber, M.C., Structural changes of the heart during severe sepsis or septic shock. Shock 37 (2012), 449–456.
11. Deep, A., Goonasekera, C.D., Wang, Y., Brierley, J., Evolution of haemodynamics and outcome of fluid-refractory septic shock in children. Intensive Care Med 39 (2013), 1602–1609.
12. Ranjit, S., Kissoon, N., Bedside echocardiography is useful in assessing children with fluid and inotrope resistant septic shock. Indian J Crit Care Med 17 (2013), 224–230.
13. Carmona, F., Manso, P.H., Silveira, V.S., Cunha, F.Q., de Castro, M., Carlotti, A.P., Inflammation, myocardial dysfunction, and mortality in children with septic shock: an observational study. Pediatr Cardiol 35 (2014), 463–470.
14. Goldstein, B., Giroir, B., Randolph, A., International consensus conference on pediatric sepsis. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6 (2005), 2–8.
15. Laks, D., Ferritina como marcador de resposta inflamatória sistêmica de crianças criticamente doente. [Thesis], 2010, Programa de Pós-Graduação em Medicina/Pediatria e Saúde da Criança. Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS).
16. Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., Recommendations for chamber quantification. Eur J Echocardiogr 7 (2006), 79–108.
17. Schoenfeld, D.A., Bernard, G.R., ARDS Network. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 30 (2002), 1772–1777.
18. Brierley, J., Carcillo, J.A., Choong, K., Cornell, T., Decaen, A., Deymann, A., et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med 37 (2009), 666–688.
19. Slater, A., Shann, F., Pearson, G., Paediatric Index of Mortality (PIM) Study Group. PIM2: a revised version of the Paediatric Index of Mortality. Intensive Care Med 29 (2003), 278–285.
20. Choong, K., Bohn, D., Fraser, D.D., Gaboury, I., Hutchison, J.S., Joffe, A.R., et al. Vasopressin in pediatric vasodilatory shock: a multicenter randomized controlled trial. Am J Respir Crit Care Med 180 (2009), 632–639.
21. Pulido, J.N., Afessa, B., Masaki, M., Yuasa, T., Gillespie, S., Herasevich, V., et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock. Mayo Clin Proc 87 (2012), 620–628.
22. Furian, T., Aguiar, C., Prado, K., Ribeiro, R.V., Becker, L., Martinelli, N., et al. Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality. J Crit Care, 27, 2012 319.e9-e15.
23. Hatherill, M., Tibby, S.M., Sykes, K., Turner, C., Murdoch, I.A., Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 81 (1999), 417–421.